ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QJ02...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
- J02AA01 Amphotericin B
- J02AA02 Hachimycin
- J02AB01 Miconazole
- J02AB02 Ketoconazole
- QJ02AB90 Clotrimazole
J02AC Triazole derivatives
- J02AC01 Fluconazole
- J02AC02 Itraconazole
- J02AC03 Voriconazole
- J02AC04 Posaconazole
J02AX Other antimycotics for systemic use
- J02AX01 Flucytosine
- J02AX04 Caspofungin
- J02AX05 Micafungin
- J02AX06 Anidulafungin
References
|
Antifungals (D01 and J02) |
|
Wall/
membrane |
|
|
|
|
|
|
topical: Bifonazole, Clomidazole, Clotrimazole#, Croconazole, Econazole, Fenticonazole, Ketoconazole, Isoconazole, Miconazole#, Neticonazole, Oxiconazole, Sertaconazole, Sulconazole, Tioconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intracellular |
|
|
| Others |
|
|
#WHO-EM. ‡Withdrawn from market. CLINICAL TRIALS: †Phase III. §Never to phase III
see also diseases |
|
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
